CCR5 and CXCR4 antagonist and agonist binding sites

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: CCR5 and CXCR4 antagonist and agonist binding sites ; volume:3 ; number:1 ; day:21 ; month:12 ; year:2006 ; pages:1 ; date:12.2006
Retrovirology ; 3, Heft 1 (21.12.2006), 1, 12.2006

Creator: Teintze, Martin

Contributor: Wilkinson, Royce
Grieco, Paul
Mills, John
Dratz, Edward
SpringerLink (Online service)

DOI: 10.1186/1742-4690-3-S1-S39

URN: urn:nbn:de:1111-2016080655710

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Teintze, Martin
Wilkinson, Royce
Grieco, Paul
Mills, John
Dratz, Edward
SpringerLink (Online service)

Other Objects (12)

CCR5 Antagonist and Agonist Binding Site Structures

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

Discovery and characterization of an endogenous CXCR4 antagonist

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5

Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

CCR5 Antagonist and Agonist Binding Site Structures

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

Discovery and characterization of an endogenous CXCR4 antagonist

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5

Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

CCR5 Antagonist and Agonist Binding Site Structures

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

Discovery and characterization of an endogenous CXCR4 antagonist

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5

Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CCR5 and CXCR4 antagonist and agonist binding sites

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

CCR5 Antagonist and Agonist Binding Site Structures

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

Discovery and characterization of an endogenous CXCR4 antagonist

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5

Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

CCR5 Antagonist and Agonist Binding Site Structures

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

Discovery and characterization of an endogenous CXCR4 antagonist

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5

Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

CCR5 Antagonist and Agonist Binding Site Structures

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4

Discovery and characterization of an endogenous CXCR4 antagonist

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5

Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

Related objects

Reset password